Impact of radiation-induced nausea and vomiting on quality of life

[1]  P. Mazzola,et al.  Nausea, vomiting and quality of life of patients with cancer undergoing antineoplastic treatment: an evaluation by pharmacists , 2015, International Journal of Pharmacy Practice.

[2]  C DeAngelis,et al.  Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting-a pilot study. , 2015, Current oncology.

[3]  Liying Zhang,et al.  Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the Functional Living Index—Emesis (FLIE) quality-of-life tool , 2015, Supportive Care in Cancer.

[4]  A. Sahgal,et al.  Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study. , 2014, Current oncology.

[5]  P. Feyer,et al.  Radiation induced nausea and vomiting. , 2014, European journal of pharmacology.

[6]  N. Darmani.  Preface. New vistas in the pharmacology and neurochemistry of diverse causes of nausea and vomiting. , 2014, European Journal of Pharmacology.

[7]  I. Olver,et al.  Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster , 2013, Supportive Care in Cancer.

[8]  E. Maranzano,et al.  Radiotherapy-induced nausea and vomiting , 2011, Expert review of pharmacoeconomics & outcomes research.

[9]  M. Kris,et al.  Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  R. Stephens,et al.  The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Pearson,et al.  Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant. , 2003, European journal of cancer.

[12]  P. Feyer,et al.  Aetiology and prevention of emesis induced by radiotherapy , 1998, Supportive Care in Cancer.

[13]  J. Osterhaus,et al.  Quality of life consequences of chemotherapy-induced emesis , 1992, Quality of Life Research.

[14]  R. Orecchia,et al.  A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  G. Steineck,et al.  One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient , 2008, Supportive Care in Cancer.